This article was originally published in The Gray Sheet
Supplier of hyaluronic acid biomaterials for medical applications is acquired by diversified materials science firm Landec Corporation for $40 million up-front, plus assumed debt of $4 million and up to $10 million in future milestone payments. Lifecore Biomedical went private in a 2008 buyout deal with private equity firm Warburg Pincus; Lifecore's dental unit then merged with Warburg Pincus portfolio firm Keystone Dental (1"The Gray Sheet" Feb. 18, 2008)
You may also be interested in...
Dental implant maker Lifecore Biomedical is on-track to be acquired by private equity firm Warburg Pincus for $239 million after failing to receive a superior proposal, the firm said Feb. 14
Recent and upcoming US FDA advisory committee meetings and a summary of topics covered.
A review by a government watchdog found the FDA’s review process for COVID-19 diagnostics was plagued by issues including allowing low-quality tests to slip through, high reviewer workloads, and manufacturer frustration.